May 04, 2016 4:56 AM ET

Health Care Technology

Company Overview of Molecular Health GmbH

Company Overview

Molecular Health GmbH designs and develops software systems that perform integrated analyses of clinical and genetic patient data to support treatment decisions and offer related services. It provides SafetyMAP, a content and analytics solution for drug de-risking and drug safety analysis for research by regulatory authorities and the pharmaceutical and health insurance industries; and InsightMAP that includes professional research services and custom solutions that support drug research and development. The company also offers TreatmentMAP, a medical device that generates an individualized tumor analysis and clinical interpretation for evidence-based targeted therapy identification based up...

Kurfuersten-Anlage 21

Heidelberg,  69115


Founded in 2004


49 6221 43851 0


49 6221 43851 100

Key Executives for Molecular Health GmbH

Chief Executive Officer and President
Founder and Chairman
Age: 53
Chief Operating Officer
Chief Innovation Officer
Compensation as of Fiscal Year 2015.

Molecular Health GmbH Key Developments

Molecular Health Opens Berlin Office to Support Growing Demand for Digital Health Solutions

Molecular Health announced that the company has opened an office in Berlin, Germany to accelerate the growing European demand for its suite of digital health solutions. Located on Friedrichstrasse in downtown Berlin close to the government district, the new office reflects Molecular Health's continued corporate growth and will enable the company to further strengthen its relationships with policy makers and patient advocacy groups in Germany.

Molecular Health GmbH Presents at Hume Brophy 7th Annual Healthcare Conference, Oct-15-2015

Molecular Health GmbH Presents at Hume Brophy 7th Annual Healthcare Conference, Oct-15-2015 . Venue: CityPoint, 1 Ropemaker Street, London EC2Y 9SS, United Kingdom.

Molecular Health Licenses SafetyMAP(TM) to U.S. Food and Drug Administration (FDA)

Molecular Health has entered into a commercial license to provide the FDA with use of its SafetyMAPTM software - formally known as Molecular Analysis of Side Effect information (MASETM), to provide a comprehensive and dynamic analytical solution for the detection and molecular analysis of drug-induced adverse events for all marketed drugs and for predicting safety issues of new drug candidates. The license supplies the FDA with access to SafetyMAP for 10 concurrent users for a period of one year and can be extended for two additional years at the discretion of the FDA. The FDA described in its RFQ the important capability that Molecular Health's technology provides: Drug safety prediction and the evaluation of post-marketing signals depend on the ability to find scientific data that can confirm relationships among drugs, drug targets, toxicity mechanism, patient susceptibility and clinical response. This requires the ability to interrogate a wide variety of data sources, including the FAERS database, MEDLINE, gene and protein databases, FDA drug product labels, patents and other document repositories to uncover hidden relationships between scientific findings and adverse events. The creation of molecular target adverse event profiles is advancing safety science. This capability is mission critical for assessing the importance of possible safety issues pre- and post-approval and for supporting regulatory science mission at FDA.

Similar Private Companies By Industry

Company Name Region
exelonix GmbH Europe
CLS Laborautomationssysteme GmbH Europe
Rendoscopy AG Europe

Recent Private Companies Transactions

Private Placement
November 16, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Molecular Health GmbH, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at